Feature Paper in Antibiotics for 2019
There has been much speculation about a possible antibiotic Armageddon; this would be the result of having untreatable post-operative infections, and similarly untreatable complications after chemotherapy. The now famous “O’Neill Report” (https://amr-review.org/) suggests that more people could die...
Saved in:
Sonstige: | |
---|---|
Year of Publication: | 2020 |
Language: | English |
Physical Description: | 1 electronic resource (282 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993545835204498 |
---|---|
ctrlnum |
(CKB)5400000000044635 (oapen)https://directory.doabooks.org/handle/20.500.12854/69089 (EXLCZ)995400000000044635 |
collection |
bib_alma |
record_format |
marc |
spelling |
Lipman, Jeffrey edt Feature Paper in Antibiotics for 2019 Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020 1 electronic resource (282 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier There has been much speculation about a possible antibiotic Armageddon; this would be the result of having untreatable post-operative infections, and similarly untreatable complications after chemotherapy. The now famous “O’Neill Report” (https://amr-review.org/) suggests that more people could die from resistant bacterial infections by 2050 than from cancer. We are still learning about all the subtle drivers of antibiotic resistance, and realizing that we need a single “whole of health” co-ordinated policy. We ingest what we sometimes feed to animals. There do not seem to be any new classes of antibiotics on our horizon. Perhaps something that has been around “forever” will come to our rescue—bacteriophages! Nevertheless, we have to do things differently, use antibiotics appropriately, for the correct indication, for the correct duration and with the correct dose, and with that, practice good antibiotic stewardship. Whilst by no means comprehensive, this book does cover some of the many topics of antibiotic stewardship. It also addresses some of the older antibiotics, some new combinations, and even some new agents. Last, and by no means least, there are two excellent articles on bacteriophages. English Medicine bicssc Antimicrobial resistance antibiotics antimicrobial stewardship inappropriate prescribing days of therapy Start Smart then Focus piperine piperlongumine antibacterial antifungal synergy non-target feed florfenicol thiamfenicol chloramfenicol HPLC-MS/MS validation swine out-of-hours care primary care quality of care quality indicators practitioners cooperative antibiotic stewardship fluoroquinolones guidelines urinary tract infections quality improvement general practitioners guideline health inequalities health equity assessment tool public health Enterobacteriaceae carbapenem-resistant CRE antibiotic resistance antimicrobials bacteriophages biofilms novel antimicrobials Antibiotics resistance broad-spectrum agents hospital epidemiology antibiotic utilization infection control infection prevention Pseudomonas aeruginosa Acinetobacter baumannii extended-spectrum beta-lactamases carbapenem-resistant Enterobacteriaceae methicillin-resistant Staphylococcus aureus clinical trials infectious disease phage therapy silver complexes camphorimine anti-Candida activity antifungals antibacterials efflux inhibitors efflux pumps erm(41) mutations mycobacteria verapamil actinomycetes bioactivity polyketides polyketide synthases biosynthesis antimicrobial resistance economic evaluation cost-utility analysis cost-effectiveness analysis policy analysis One Health Singapore antibiotic prescribing implementation behavior change stakeholder consultation 3-03943-122-6 3-03943-123-4 Lipman, Jeffrey oth |
language |
English |
format |
eBook |
author2 |
Lipman, Jeffrey |
author_facet |
Lipman, Jeffrey |
author2_variant |
j l jl |
author2_role |
Sonstige |
title |
Feature Paper in Antibiotics for 2019 |
spellingShingle |
Feature Paper in Antibiotics for 2019 |
title_full |
Feature Paper in Antibiotics for 2019 |
title_fullStr |
Feature Paper in Antibiotics for 2019 |
title_full_unstemmed |
Feature Paper in Antibiotics for 2019 |
title_auth |
Feature Paper in Antibiotics for 2019 |
title_new |
Feature Paper in Antibiotics for 2019 |
title_sort |
feature paper in antibiotics for 2019 |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2020 |
physical |
1 electronic resource (282 p.) |
isbn |
3-03943-122-6 3-03943-123-4 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT lipmanjeffrey featurepaperinantibioticsfor2019 |
status_str |
n |
ids_txt_mv |
(CKB)5400000000044635 (oapen)https://directory.doabooks.org/handle/20.500.12854/69089 (EXLCZ)995400000000044635 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Feature Paper in Antibiotics for 2019 |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1787548474313539584 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04940nam-a2201285z--4500</leader><controlfield tag="001">993545835204498</controlfield><controlfield tag="005">20231214133228.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000044635</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/69089</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000044635</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lipman, Jeffrey</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Feature Paper in Antibiotics for 2019</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (282 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">There has been much speculation about a possible antibiotic Armageddon; this would be the result of having untreatable post-operative infections, and similarly untreatable complications after chemotherapy. The now famous “O’Neill Report” (https://amr-review.org/) suggests that more people could die from resistant bacterial infections by 2050 than from cancer. We are still learning about all the subtle drivers of antibiotic resistance, and realizing that we need a single “whole of health” co-ordinated policy. We ingest what we sometimes feed to animals. There do not seem to be any new classes of antibiotics on our horizon. Perhaps something that has been around “forever” will come to our rescue—bacteriophages! Nevertheless, we have to do things differently, use antibiotics appropriately, for the correct indication, for the correct duration and with the correct dose, and with that, practice good antibiotic stewardship. Whilst by no means comprehensive, this book does cover some of the many topics of antibiotic stewardship. It also addresses some of the older antibiotics, some new combinations, and even some new agents. Last, and by no means least, there are two excellent articles on bacteriophages.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Antimicrobial resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobial stewardship</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inappropriate prescribing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">days of therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Start Smart then Focus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">piperine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">piperlongumine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibacterial</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antifungal</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">synergy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-target feed</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">florfenicol</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">thiamfenicol</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chloramfenicol</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HPLC-MS/MS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">validation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">swine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">out-of-hours care</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">primary care</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">quality of care</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">quality indicators</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">practitioners cooperative</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic stewardship</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fluoroquinolones</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">guidelines</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">urinary tract infections</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">quality improvement</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">general practitioners</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">guideline</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">health inequalities</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">health equity assessment tool</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">public health</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Enterobacteriaceae</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">carbapenem-resistant</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CRE</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobials</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bacteriophages</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biofilms</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">novel antimicrobials</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Antibiotics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">broad-spectrum agents</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hospital epidemiology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic utilization</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">infection control</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">infection prevention</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pseudomonas aeruginosa</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Acinetobacter baumannii</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">extended-spectrum beta-lactamases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">carbapenem-resistant Enterobacteriaceae</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">methicillin-resistant Staphylococcus aureus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clinical trials</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">infectious disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phage therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">silver complexes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">camphorimine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anti-Candida activity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antifungals</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibacterials</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">efflux inhibitors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">efflux pumps</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">erm(41)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mutations</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mycobacteria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">verapamil</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">actinomycetes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bioactivity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polyketides</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polyketide synthases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biosynthesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobial resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">economic evaluation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cost-utility analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cost-effectiveness analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">policy analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">One Health</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Singapore</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic prescribing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">implementation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">behavior change</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">stakeholder consultation</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-122-6</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-123-4</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lipman, Jeffrey</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:47:08 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338103080004498&Force_direct=true</subfield><subfield code="Z">5338103080004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338103080004498</subfield></datafield></record></collection> |